Bacteriophage Salmonella Group ABCDE, vial of 100 ml
Salmonella bacteriophage groups A, B, C, D, E liquid
The drug causes a specific lysis of Salmonella serotypes mentioned above.
- diseases or bacteriocarrier caused by Salmonella serotypes mentioned above.
An important condition for effective phage therapy is a preliminary determination of phage sensitivity and early use of the drug.
The use of the drug is possible in combination with other drugs, including antibiotics.
How to take, the course of administration and dosage
The drug is intended for internal use. For treatment, bacteriophage is taken 3 times a day through the mouth 1 hour before meals from the first day of illness for 7-10 days. In case of a disease characterized by a mild colitis syndrome, and during the recovery period, it is recommended to administer the drug rectally, in the form of enemas, instead of 1 dose by mouth, during oral administration.
Recommended dosage of the drug
Mode of administration
Through the mouth (dose at a time)
Up to 6 months
From 6 months to 1 year
10- 15 ml
From 1 year to 3 years
From 3 years to 8 years
From 8 years and older
For prophylactic purposes, the drug is recommended to prevent bacteriocarrier, nosocomial infection, during group diseases in organized groups and families. Optimal regimens - daily intake of a single dose, depending on age. The duration of the drug is determined by the conditions of the epidemiological situation.
Before use, the bottle with a liquid bacteriophage must be shaken. When cloudy do not use!
Influence on ability to drive motor transport and control mechanisms
The use of the drug does not affect the ability to drive vehicles, mechanisms.
Oral and topical solution
Storage in accordance with SP 126.96.36.1998-03 at a temperature of from 2 to 8 ° C in a dry, dark place and out of reach of children.